MAD Trial: Myopia Atropine Dose

PHASE3RecruitingINTERVENTIONAL
Enrollment

550

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

March 1, 2029

Study Completion Date

April 1, 2029

Conditions
Progressive Myopia
Interventions
DRUG

Atropine Ophthalmic 0.05%

Atropine 0.05% sulphate ophthalmic solution

DRUG

Atropine Ophthalmic 0.5%

Atropine 0.5% sulphate ophthalmic solution

Trial Locations (20)

Unknown

RECRUITING

Flevoziekenhuis, Almere Stad

RECRUITING

OLVG, locatie Oost, Amsterdam

RECRUITING

Ophthalmologistenpraktijk Delfland, Delft

RECRUITING

Reinier de Graaf Gasthuis, Delft

RECRUITING

Deventer Ziekenhuis, Deventer

RECRUITING

Albert Schweitzer ziekenhuis, Dordrecht

RECRUITING

Bergman Clinics - Ede, Ede

RECRUITING

Admiraal de Ruyter Ziekenhuis, Goes

RECRUITING

Frisius MC, Heerenveen

RECRUITING

Oogcentrum Noordholland, Heerhugowaard

RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Bergman Clinics - Lelystad, Lelystad

RECRUITING

Maastricht UMC+, Maastricht

RECRUITING

St. Antonius, Nieuwegein

RECRUITING

Radboudumc, Nijmegen

RECRUITING

Erasmus Medical Center, Rotterdam

RECRUITING

Haga Ziekenhuis, The Hague

RECRUITING

Oogkliniek Den Haag, The Hague

RECRUITING

Ziekenhuis Rivierenland Tiel, Tiel

RECRUITING

Elisabeth-TweeSteden Ziekenhuis, Tilburg

Sponsors
All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Erasmus Medical Center

OTHER